OTCM
RNGE
Market cap71mUSD
Jul 09, Last price
0.88USD
1D
14.29%
1Q
388.89%
Jan 2017
-70.67%
IPO
120.00%
Name
Malachite Innovations Inc
Chart & Performance
P/E
3.71
P/S
19.17
EPS
0.24
Div Yield, %
—
Shrs. gr., 5y
16.23%
Rev. gr., 5y
123.01%
Revenues
4m
-58.82%
Net income
19m
P
CFO
123k
P
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Malachite Innovations, Inc., established in Cleveland, Ohio, in 2007, pursues a dual business strategy. Operating through its subsidiaries, the company delivers health and wellness products across the United States, featuring a comprehensive collection of nearly 100 innovative cannabosides, including glycosylated tetrahydrocannabinol, cannabidiol, cannabidivarin, and cannabinol. The firm is also advancing the development of THC-glycoside (VBX-100), an oral prodrug intended for treating gastrointestinal conditions such as inflammatory bowel disease and irritable bowel syndrome. Additionally, Malachite Innovations dedicates efforts to identifying, funding, and revitalizing environmental ventures, prioritizing advanced technology and sustainable practices. The company adopted its current name in October 2021, having previously operated as Vitality Biopharma, Inc.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑03 | 2020‑03 | 2019‑03 | 2018‑03 | 2017‑03 | |
| Income | |||||||||
Revenues | |||||||||
Cost of revenue | |||||||||
Unusual Expense (Income) | |||||||||
NOPBT | |||||||||
NOPBT Margin | |||||||||
Operating Taxes | |||||||||
Tax Rate | |||||||||
NOPAT | |||||||||
Net income | |||||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | |||||||||
BB yield | |||||||||
| Debt | |||||||||
Debt current | |||||||||
Long-term debt | |||||||||
Deferred revenue | |||||||||
Other long-term liabilities | |||||||||
Net debt | |||||||||
| Cash flow | |||||||||
Cash from operating activities | |||||||||
CAPEX | |||||||||
Cash from investing activities | |||||||||
Cash from financing activities | |||||||||
FCF | |||||||||
| Balance | |||||||||
Cash | |||||||||
Long term investments | |||||||||
Excess cash | |||||||||
Stockholders' equity | |||||||||
Invested Capital | |||||||||
ROIC | |||||||||
ROCE | |||||||||
| EV | |||||||||
Common stock shares outstanding | |||||||||
Price | |||||||||
Market cap | |||||||||
EV | |||||||||
EBITDA | |||||||||
EV/EBITDA | |||||||||
Interest | |||||||||
Interest/NOPBT | |||||||||